comparemela.com
Home
Live Updates
Cytokinetics Announces Positive Topline Data for Aficamten in SEQUOIA-HCM : comparemela.com
Cytokinetics Announces Positive Topline Data for Aficamten in SEQUOIA-HCM
On December 27, 2023, Cytokinetics announced positive topline results from the phase 3 SEQUOIA-HCM trial evaluating aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy
Related Keywords
United States ,
America ,
Fadyi Malik ,
Martin Maron ,
Society Scientific Sessions ,
Cytokinetics Inc ,
Academy Martin Maron ,
Heart Failure Society Of America ,
Hypertrophic Cardiomyopathy Center ,
Lahey Hospital ,
Heart Failure Society ,
Scientific Meeting ,
comparemela.com © 2020. All Rights Reserved.